Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:13 AM
Ignite Modification Date:
2025-12-25 @ 2:13 AM
NCT ID:
NCT04546360
Eligibility Criteria:
Inclusion Criteria:
* age 18-75 years;
* confirmed cirrhosis based on liver biopsy or clinical findings;
* without decompensated events (e.g. ascites, bleeding, or overt encephalopathy);
* scheduled to undergo esophagogastroduodenoscopy, spleen stiffness measurement and liver stiffness measurement;
* estimated survival time\>24 months, and model for end-stage liver disease score\<19, and without liver transplant;
* with written informed consent.
Exclusion Criteria:
* contradictions for esophagogastroduodenoscopy;
* accepted primary prevention (non-selective beta blockers or endoscopic variceal ligation);
* time frame between elastography measurement and esophagogastroduodenoscopy\>14 days;
* diagnosed as hepatocellular carcinoma;
* absence of spleen or splenectomy.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
75 Years
Study:
NCT04546360
Study Brief:
Protocol Section:
NCT04546360